Pritzker/Vlock Family Office
Venture Capital
Active
New Haven, United States
14
28M
9
1
0.36
2
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Chicago. The venture was found in North America in United States.
Opposing the other organizations, this Pritzker/Vlock Family Office works on 4 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Pritzker/Vlock Family Office, startups are often financed by Larry Bock, Andrew Mitchell, Thomas Lehrman. The meaningful sponsors for the fund in investment in the same round are PureTech Health, Virgin Group, Tom Christopoul. In the next rounds fund is usually obtained by Virgin Group, PureTech Health, Invesco.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Gelesis, Ubiquity Global Services, ZOZI. We can highlight the next thriving fund investment areas, such as Biotechnology, Tourism. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investor highlights
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 1
- Exits
- 2
- Follow on index
- 0.36
- Investments by industry
- Biotechnology (6)
- Health Care (5)
- Medical Device (4)
- Software (4)
- Diabetes (3) Show 18 more
- Investments by region
-
- United States (14)
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 188M
- Group Appearance index
- 0.71
- Avg. company exit year
- 8
- Avg. multiplicator
- 5.32
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Retia Medical | 18 Jul 2022 | Biotechnology, Software, Hardware | Early Stage Venture | 15M | United States, New York, Valhalla |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.